We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Southwest Gas
SWX
$6.56B
| $506K | ﹤0.01% |
7,325
-1,301
| -15% | -$94.6K |
|
927
New Jersey Resources
NJR
$5.45B
| $501K | ﹤0.01% |
15,344
-17,093
| -53% | -$566K |
|
|
TRHC
928
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $492K | ﹤0.01% |
8,984
-952
| -10% | -$54.5K |
|
|
EVBG
929
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $484K | ﹤0.01% |
+3,500
| New | +$455K |
|
|
CONN
930
DELISTED
Conn's Inc.
CONN
| $483K | ﹤0.01% |
47,834
+22,519
| +89% | +$149K |
|
931
CALL
Xerox
XRX
$427M
| $482K | ﹤0.01% |
31,500
| – | – |
|
932
Sunrun
RUN
$2.38B
| $471K | ﹤0.01% |
23,881
-29,910
| -56% | -$458K |
|
|
VRNT
933
DELISTED
Verint Systems
VRNT
| $471K | ﹤0.01% |
+20,470
| New | +$453K |
|
934
Inogen
INGN
$160M
| $462K | ﹤0.01% |
13,011
-108,185
| -89% | -$4.56M |
|
|
CIVI
935
DELISTED
Civitas Resources
CIVI
| $459K | ﹤0.01% |
+30,959
| New | +$505K |
|
|
FIT
936
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $452K | ﹤0.01% |
70,000
| – | – |
|
937
Old National Bancorp
ONB
$10.1B
| $451K | ﹤0.01% |
32,743
-52,507
| -62% | -$708K |
|
938
Axos Financial
AX
$5.63B
| $441K | ﹤0.01% |
19,954
-53,959
| -73% | -$1.1M |
|
939
Southside Bancshares
SBSI
$953M
| $439K | ﹤0.01% |
+15,841
| New | +$450K |
|
940
Supernus Pharmaceuticals
SUPN
$2.74B
| $439K | ﹤0.01% |
18,475
+1,759
| +11% | +$38.9K |
|
941
CRISPR Therapeutics
CRSP
$5.17B
| $438K | ﹤0.01% |
+5,963
| New | +$349K |
|
942
Simulations Plus
SLP
$371M
| $437K | ﹤0.01% |
+7,301
| New | +$321K |
|
943
Axcelis
ACLS
$4.1B
| $436K | ﹤0.01% |
+15,663
| New | +$382K |
|
|
CARV
944
DELISTED
Carver Bancorp
CARV
| $436K | ﹤0.01% |
+70,171
| New | +$205K |
|
|
WBA
945
DELISTED
Walgreens Boots Alliance
WBA
| $434K | ﹤0.01% |
10,248
-130,978
| -93% | -$5.56M |
|
946
Neogen
NEOG
$2.49B
| $428K | ﹤0.01% |
11,020
-30,816
| -74% | -$1.04M |
|
|
MTSC
947
DELISTED
MTS Systems Corp
MTSC
| $428K | ﹤0.01% |
+24,342
| New | +$450K |
|
948
ONE Gas
OGS
$4.96B
| $422K | ﹤0.01% |
5,479
-5,646
| -51% | -$456K |
|
949
Century Aluminum
CENX
$5.14B
| $419K | ﹤0.01% |
+58,795
| New | +$311K |
|
|
LTHM
950
DELISTED
Livent Corporation
LTHM
| $418K | ﹤0.01% |
67,844
-94,943
| -58% | -$598K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.